Published in Acta Pharmacol Sin on November 18, 2013
Progesterone for the Treatment of Traumatic Brain Injury III (ProTECT) | NCT00822900
Clinical evidence of inflammation driving secondary brain injury: a systematic review. J Trauma Acute Care Surg (2015) 0.97
Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol (2016) 0.90
Investigational agents for treatment of traumatic brain injury. Expert Opin Investig Drugs (2015) 0.84
The Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future Directions. Front Neurol (2016) 0.80
Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature. CNS Drugs (2016) 0.77
Adaptation of Traumatic Brain Injury Guidelines in Iran. Trauma Mon (2016) 0.75
Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway. Neurocrit Care (2017) 0.75
The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cells. Microb Cell (2017) 0.75
Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54
ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med (2006) 2.86
Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol (2007) 2.68
Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci (2010) 2.40
Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care (2008) 2.33
Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma (2000) 2.30
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA (2012) 2.06
Guidelines for the management of severe head injury. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. J Neurotrauma (1996) 2.04
Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res (2007) 1.97
Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke (2000) 1.83
Neurosteroids: a new brain function? J Steroid Biochem Mol Biol (1990) 1.81
Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol (2004) 1.73
Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience (2004) 1.55
Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol (1997) 1.49
Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol (1991) 1.46
Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol (2006) 1.45
Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther (2007) 1.41
Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res (2005) 1.40
Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology (2005) 1.33
Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs (2010) 1.32
Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J Neurotrauma (2001) 1.26
Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport (2002) 1.22
Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res (2009) 1.16
Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab (2004) 1.16
Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience (2011) 1.11
Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res (2004) 1.10
Female sex steroids: effects upon microglial cell activation. J Neuroimmunol (2000) 1.09
Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience (2000) 1.08
Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci (1992) 1.06
Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil (2003) 1.06
Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience (2004) 1.01
Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Exp Gerontol (2005) 1.00
Gene expression of progesterone receptor isoforms in the rat brain. Horm Behav (1994) 0.98
Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension (1999) 0.98
Neurosteroids reduce inflammation after TBI through CD55 induction. Neurosci Lett (2007) 0.97
Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination. J Mol Neurosci (2006) 0.97
Multifunctional drug treatment in neurotrauma. Neurotherapeutics (2009) 0.96
Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity. Steroids (2011) 0.95
Glucocorticoid therapy in neurologic critical care. Crit Care Med (2005) 0.95
GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br J Pharmacol (1996) 0.95
The effect of progesterone dose on gene expression after traumatic brain injury. J Neurotrauma (2011) 0.94
Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci (1996) 0.93
Effects of progesterone on experimental spinal cord injury. Brain Res (2007) 0.92
A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Horm Behav (2012) 0.90
Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience (1991) 0.90
Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostaining in the lesioned spinal cord. J Neurotrauma (2006) 0.90
Efficacy of progesterone following a moderate unilateral cortical contusion injury. J Neurotrauma (2008) 0.87
[Clinical study on the therapeutic effects and mechanism of progesterone in the treatment for acute severe head injury]. Zhonghua Wai Ke Za Zhi (2007) 0.86
Progesterone treatment alters neurotrophin/proneurotrophin balance and receptor expression in rats with traumatic brain injury. Restor Neurol Neurosci (2012) 0.84
Expression of glutamate receptor subunits in the hypothalamus of the female rat during the afternoon of the proestrous luteinizing hormone surge and effects of antiprogestin treatment and aging. Neuroendocrinology (2005) 0.81
Gestation confers temporary resistance to peroxidation in the maternal rat brain. Neurosci Lett (1993) 0.80
[Effects of β-lactam antibiotics ceftriaxone on expression of glutamate in hippocampus after traumatic brain injury in rats]. Zhejiang Da Xue Xue Bao Yi Xue Ban (2011) 0.76